Among younger AD patients, those with atypical presentations tend to show similar degrees of cortical tau uptake on PET compared to amnestic AD, but lower uptake in hippocampus and entorhinal regions (Whitwell et al., 2018a; Josephs et al., 2020b). The gene discussed is MAPT; the disease is Alzheimer disease.